What are ranimustine drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ranimustine drugs are pharmacologic agents that share a common mechanism. 0 are currently marketed, with 2 more in clinical development.

ranimustine

0 marketed 1 in Phase 3 1 in Phase 2

This page covers all ranimustine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 3 pipeline (1)

Cymerin · Oncology
Cymerin works by interfering with DNA replication and transcription, ultimately leading to cell death.

Phase 2 pipeline (1)

NIMUSTINE · Oncology
Nimustine works by inducing DNA damage through the formation of cross-links and strand breaks.

Patent intelligence

nimustine patent landscape — aggregated cliff calendar, attackable patents, originator estates